Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

115.45 +7.47 (+6.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
From Lantheus Holdings, Inc.
Via GlobeNewswire
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced. 
Via Chartmill
Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued gem with solid fundamentals. 
Via Chartmill
NASDAQ:LNTH—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a strong growth stock, setting up for a breakout. 
Via Chartmill
Unlocking the Growth Potential of NASDAQ:LNTH.
Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) suited for growth investing? 
Via Chartmill
New Year, New Gains: The 3 Best AI Stocks to Buy in 2024
These AI stocks offer substantial upside potential compared to the overextended chip players that dominated the theme in 2023. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today?
Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic castration-res 
Via Benzinga
The Latest Analyst Ratings for Lantheus Holdings
Via Benzinga
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is showing decent growth, but is still valued reasonably. 
Via Chartmill
Exploring the Growth Potential of NASDAQ:LNTH as It Nears a Breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH, an undervalued stock with good fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is probably undervalued for the fundamentals it is displaying. 
Via Chartmill
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
Despite its growth, NASDAQ:LNTH remains within the realm of affordability. 
Via Chartmill
DexCom Stock Earns Healthy Relative Strength Rating Upgrade
In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday. 
Via Investor's Business Daily
When you look at NASDAQ:LNTH, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
Lantheus to Present at the Jefferies London Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
Despite its growth, NASDAQ:LNTH remains within the realm of affordability. 
Via Chartmill
Lantheus Reports Third Quarter 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Low-Risk Stock Picks to Double Your Money
As we get closer to the new year, investors may want to consider these top, low-risk stocks to double your money. 
Via InvestorPlace
Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Don't overlook NASDAQ:LNTH—it's a hidden gem with strong fundamentals and an attractive price tag.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued gem with solid fundamentals. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.